DOAJ Open Access 2020

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

Robin Jacob, MD Paolo Strati, MD Nicolas Palaskas, MD Juan C. Lopez-Mattei, MD Konstantinos Marmagkiolis, MD +3 lainnya

Abstrak

A 66-year-old woman with follicular lymphoma on lenalidomide and rituximab presented with chest pain. High-sensitivity troponin T peaked at 7,566 ng/l. Cardiac biopsy revealed extensive inflammation consistent with medication-induced myocarditis. Lenalidomide was stopped with improvement in troponins and patient was initiated on high-dose corticosteroid therapy. (Level of Difficulty: Intermediate.)

Topik & Kata Kunci

Diseases of the circulatory (Cardiovascular) system

Penulis (8)

Robin Jacob, MD

Paolo Strati, MD

Nicolas Palaskas, MD

Juan C. Lopez-Mattei, MD

Konstantinos Marmagkiolis, MD

L. Maximilian Buja, MD

Anita Deswal, MD

Cezar Iliescu, MD

Format Sitasi

APA MLA BibTeX

MD, R.J., MD, P.S., MD, N.P., MD, J.C.L., MD, K.M., MD, L.M.B. et al. (2020). Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy. https://doi.org/10.1016/j.jaccas.2020.07.033

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1016/j.jaccas.2020.07.033

Informasi Jurnal

Tahun Terbit: 2020
Sumber Database: DOAJ
DOI: 10.1016/j.jaccas.2020.07.033
Akses: Open Access ✓